NASDAQ:BTMD biote Q3 2026 Earnings Date & Estimates $1.15 -0.02 (-1.71%) Closing price 04:00 PM EasternExtended Trading$1.16 +0.01 (+0.87%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. biote is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 5:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeAfter Market ClosesConference Call5:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from biote in Q3 2026biote is expected to post earnings of -$0.05 per share on revenue of $44.01 million. In the same quarter a year earlier biote reported $0.22 per share on revenue of $47.96 million. biote last reported on August 5, 2026, posting -$0.23 per share and missing the $0.0267 consensus estimate. biote has beaten the consensus EPS estimate in 6 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.05Expected Revenue$44.01 millionPrior-Year EPS$0.22Prior-Year Revenue$47.96 millionExpected EPS Growth-122.7%Expected Revenue Growth-8.2%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.23 (Missed by -$0.2567)Last Quarter Revenue$44.23 millionEPS Beat Rate6 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report biote Q3 2026 Earnings FAQ When does biote report Q3 2026 earnings? biote (NASDAQ:BTMD) is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. What time is biote's Q3 2026 earnings call? biote's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for biote? Analysts expect biote to post earnings of -$0.05 per share for Q3 2026. How much revenue is biote expected to report? The consensus revenue estimate for biote is $44.01 million for Q3 2026. biote Earnings HeadlinesComparing biote (NASDAQ:BTMD) and Hims & Hers Health (NYSE:HIMS)October 7 at 6:15 AM | americanbankingnews.combiote (NASDAQ:BTMD) Stock Falls 2.6% - Here's WhyOctober 6 at 2:32 AM | americanbankingnews.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.October 9 at 1:00 AM | Porter & Company (Ad)Contrasting biote (NASDAQ:BTMD) and Gaxos.ai (NASDAQ:GXAI)September 29, 2026 | americanbankingnews.combiote Corp (BTMD) Stock Forecast & Price TargetSeptember 23, 2026 | investing.comTD Cowen Reaffirms Their Buy Rating on biote (BTMD)September 17, 2026 | theglobeandmail.comSee More biote Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like biote? Sign up for Earnings360's daily newsletter to receive timely earnings updates on biote and other key companies, straight to your email. Email Address About biotebiote (NASDAQ:BTMD) is a healthcare company focused on hormone optimization and personalized wellness. The company supports physicians and other healthcare providers who use its BioTE Method, a hormone replacement approach that commonly involves the implantation of bioidentical hormone pellets for eligible men and women. In addition to hormone pellet products, biote offers nutritional supplements and other wellness products designed to complement hormone-related care. The company also provides affiliated medical practices with clinical education, provider training, patient-management resources, and practice-development support. Founded in 2012, biote primarily serves healthcare providers and patients in the United States through its network of affiliated practices. Its business model combines proprietary products with services intended to help medical practices deliver and manage hormone optimization programs.View biote ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt Load Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
